Compare Shell PLC (SHEL) vs 10X Genomics Inc (TXG) Price & Performance

Shell PLCTrade

10X Genomics IncTrade

Price performance (Past 24H)

Key statistics

Shell PLC vs 10X Genomics Inc — how do they compare? Shell PLC trades at $87.12 (market cap $235.24B), while 10X Genomics Inc trades at $46.82 (market cap $5.48B). The key difference: Shell PLC is far larger — about 42.9× 10X Genomics Inc's market cap, and Shell PLC pays a 3.63% dividend while 10X Genomics Inc pays none. Which is the better fit depends on your goals.

	SHEL	TXG
Market Cap	$235.24B	$5.48B
Sector	Energy	Health
52-Week High	$94.15	$45.80
52-Week Low	$70.31	$11.34
Enterprise Value	$287.77B	$5.02B
Dividend Yield	3.63%	—

View details →View details →

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

SHEL

Shell buys back 184,107 shares as part of its ongoing share repurchase program.Na · 13 hours agoBullish Oil prices top $90 as Strait of Hormuz tensions boost energy stocks, while airlines and housebuilders fall.Proactive Investors · 1 day agoNeutral View details →

TXG

New report details 1,230+ bioinformatics deals, revealing market trends and deal structures through 2026Researchandmarkets.Com · 4 days agoNeutral View details →

About Shell PLC

Shell is an integrated oil and gas company that explores for, produces, and refines oil around the world. In 2021, it produced 1.7 million barrels of liquids and 8.7 billion cubic feet of natural gas per day. At year-end 2021, reserves stood at 9.2 billion barrels of oil equivalent, 50% of which consisted of liquids. Its production and reserves are in Europe, Asia, Oceania, Africa, and North and South America. The company operates refineries with capacity of 1.8 mmb/d located in the Americas, Asia, Africa, and Europe and sells 15 mtpa of chemicals. Its largest chemical plants, often integrated with its local refineries, are in Central Europe, China, Singapore, and North America.

About 10X Genomics Inc

10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.